Page last updated: 2024-09-02

schizandrin b and Carcinoma, Non-Small Cell Lung

schizandrin b has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Yao, XM; Zhang, L	1

Other Studies

1 other study(ies) available for schizandrin b and Carcinoma, Non-Small Cell Lung

Article	Year
Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. Journal of liposome research, 2021, Volume: 31, Issue:2 Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclooctanes; Doxorubicin; Epithelial-Mesenchymal Transition; Humans; Lignans; Liposomes; Lung Neoplasms; Polycyclic Compounds; Vascular Endothelial Growth Factor A	2021

Article

Year

Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition.

Journal of liposome research, 2021, Volume: 31, Issue:2

Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclooctanes; Doxorubicin; Epithelial-Mesenchymal Transition; Humans; Lignans; Liposomes; Lung Neoplasms; Polycyclic Compounds; Vascular Endothelial Growth Factor A

2021